University of Maryland
Baltimore, Maryland 21250
60 studies enrolling now · 497 studies all time
What they study most
1st Line NSCLC, ADPKD, AML, Abdominal Cancer, Abscess, Acquired Aplastic Anemia, Activated Clotting Time, Acute Coronary Syndrome, Acute Coronary Syndrome (ACS), Acute Coronary Syndromes, Acute Decompensated Heart Failure, Acute Ischemic Stroke
Studies at this site
- Substance Use in Pregnancy - Optimizing Retention in Treatment — Recruiting now
- Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
- Continuous Dual Aspiration Technique With Zoom System for Stroke — Recruiting now
- A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus With the Indigo™ Aspiration System (STRIDE II) — Recruiting now
- An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL) — Recruiting now
- Study of AHB-137 in Chronic Hepatitis B (CHB) Participants in North America and Europe Regions — Recruiting now
- A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer — Recruiting now
- IGNITE: Study of Tirabrutinib vs Rituximab/Temozolomide for Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) — Recruiting now
- A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis — Recruiting now
- STRIVE Post-Market Registry Study — Recruiting now
- A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
- Multi-Center Clean Air Randomized Controlled Trial in COPD — Recruiting now
- Phase II Study of Platinum/Etoposide Plus Ivonescimab for Extensive-Stage Small Cell Lung Cancer — Recruiting now
- A Study of Pasritamig With Docetaxel Versus Docetaxel in Participants With Metastatic Castration-Resistant Prostate Cancer — Recruiting now
- A Phase 2 Study and Open-Label Extension of NEU-411 in Companion Diagnostic-Positive Participants With Early Parkinson's Disease — Recruiting now
- Genome Transplant Dynamics — Recruiting now
- Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer — Recruiting now
- DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis — Recruiting now
- Blood-brain Barrier (BBB) Opening Using Exablate Focused Ultrasound With Standard of Care Treatment of NSCLC Brain Mets — Recruiting now
- EF-41/KEYNOTE D58: Phase 3 Study of Optune Concomitant With Temozolomide Plus Pembrolizumab in Newly Diagnosed Glioblastoma — Recruiting now
- Study of STK-012 Alone and With Other Treatments in Patients With Advanced Lung Cancer and Other Cancers — Recruiting now
- SELUTION 4 De Novo Small Vessel IDE Trial — Recruiting now
- A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine — Recruiting now
- Gleolan for Visualization of Newly Diagnosed or Recurrent Ovarian Cancer (OVA-302) — Recruiting now
- RevCore for In Stent Thrombosis — Recruiting now
- Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). — Recruiting now
- Neural Mechanisms of Immersive Virtual Reality in Chronic Pain (VR TMD EEG) — Recruiting now
- A Patient-centered Trial of a Process-of-care Intervention in Hospitalized AKI Patients: the COPE-AKI Trial — Recruiting now
- Genetic and Environmental Risk Factors for Hemorrhagic Stroke — Recruiting now
- Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG — Recruiting now
- Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer — Recruiting now
- REMASTer: REcurrent Brain Metastases After SRS Trial — Recruiting now
- A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC) — Recruiting now
- A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30) — Recruiting now
- Erector Spinae Plane Block Versus Trigger Point Injection for Chronic Thoracic Myofascial Pain — Recruiting now
- Study of Sacituzumab Govitecan in Participants With Advanced or Metastatic Solid Tumor and Moderate Liver Impairment — Recruiting now
- Hyperbaric Oxygen Brain Injury Treatment Trial — Recruiting now
- Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis — Recruiting now
- A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting — Recruiting now
- Virtual Reality Therapy for Cancer-Treatment Associated Symptoms — Recruiting now
- A Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma — Recruiting now
- Pre-Incision Peripheral Nerve Blocks for Lower Extremity Fracture Surgery in Older Adults — Recruiting now
- A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1) — Recruiting now
- Zenith® Fenestrated+ Clinical Study — Recruiting now
- Black and African Americans Connections to Parkinson's Disease (BLAAC PD) — Recruiting now
- Is Physical Therapy Clearance Before Arthroplasty Home Discharge Necessary? — Recruiting now
- GEMINI-NSCLC: NSCLC Biomarker Study — Recruiting now
- Dose-escalation and Dose-expansion Study of Safety of Azer-cel (PBCAR0191) in Participants With Relapsed/Refractory (r/r) Non-Hodgkin Lymphoma (NHL) and r/r B-cell Acute Lymphoblastic Leukemia (B-ALL) — Recruiting now
- Improving Safety and Quality of Tracheal Intubation Practice in Pediatric ICUs — Recruiting now
- Risk Indicators of Sarcoidosis Evolution-Unified Protocol — Recruiting now